A team of academics and clinicians, led by King’s College London, are developing revolutionary technology to transform the way healthcare professionals can help patients with feelings of paranoia.
In a landmark project, experts from King’s College London, University of Bath and The McPin Foundation are working with healthtech startup Avegen Health to develop and trial a new app that will deliver a therapy called STOP (Successful Treatment Of Paranoia), which uses gamified activities and assessments, delivered weekly over twelve weeks, to give patients the tools to overcome paranoid thoughts.
By
NIHR Maudsley BRC at 11 Apr 2023
SlowMo, an inclusive, digitally supported therapy for paranoia, has been awarded £1.3 million funding by Wellcome to scale up in three NHS Trusts.
By
NIHR Maudsley BRC at 20 Jan 2023
The National Institute for Health and Care Research (NIHR) has awarded £41 million to the NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. The NIHR funding is for five years from 1 December 2022 to 30 November 2027.
By
NIHR Maudsley BRC at 14 Oct 2022
The AVATAR2 trial is a multi-centre study of therapy aiming to help people who hear distressing voices by enabling them to build an avatar to represent the owner of the voice. Referrers play a pivotal role by recommending participants take part in the trial. Here Clinical Psychologist, Dr Helen Harding, talks about the referral process and how she sees the research benefitting patients in the short and long term. Dr Harding is a Clinical Psychologist in Lambeth Community Services.
By
NIHR Maudsley BRC at 20 May 2022
The Psychosis VIEWER population health management platform has received high commendation at the 2022 HSJ Partnership Awards.
By
NIHR Maudsley BRC at 25 Mar 2022
